knowledge -WSS

knowledge

author：hotspot 2025-09-30 20:17:48 - browse：9782

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Chronically ill young patients struggle to find fertility info

explore

hotspot

WSS

Medicare threatens to cut off funding for HCA's Mission hospital

Feng Zhang, Grail founder join forces on new gene editing startup

Biden report: The neurospychology of memory and aging

Medicare threatens to cut off funding for HCA's Mission hospital

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Gilead might be held responsible for not developing a drug

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

How one medical school became remarkably diverse

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

In age of alternative facts, a scholarly course on calling out crap

Medical mystery: When a cough is not just a cough

In Memoriam: Notable people who died in 2023

Ahead of JPM, here's who's profiting most in health care

After affirmative action ruling, medical educators look to 'holistic review'

Medical mystery: When a cough is not just a cough

At least 13 dead in Texas as scorching temps continue

Federal weight loss drug coverage is 30 years out of date

knowledge

UCB departs biotech trade group BIO

Federal weight loss drug coverage is 30 years out of date

Videos point to link between seizures and unexplained toddler deaths

Antibiotic resistance and the global rise in human conflict

Feng Zhang CRISPR delivery startup lays off quarter of staff

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

explore

hotspot

hotspot

leisure time